US Stock MarketDetailed Quotes

Avai Bio (AVAI)

Watchlist
  • 0.3158
  • -0.0042-1.30%
15min DelayClose Apr 17 14:35 ET
43.67MMarket Cap-31.58P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Avai Bio (AVAI) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2025
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q4)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
0
Gross profit
0
Operating expense
22.43%553.73K
-27.29%453.02K
-5.74%487.59K
-46.34%1.14M
-252.94%-464.07K
-55.39%452.3K
55.91%623.05K
25.70%517.29K
589.99%2.13M
142.86%303.43K
Selling and administrative expenses
-22.26%318.26K
-39.08%364.35K
-2.28%481.07K
-28.60%1.44M
-124.42%-58.05K
-59.21%409.38K
58.20%598.03K
22.33%492.28K
577.58%2.02M
98.45%237.71K
-Selling and marketing expense
2,159.85%55.05K
131.33%80.56K
327.12%154.19K
182.53%85.16K
-60.84%11.8K
--2.44K
--34.83K
--36.1K
263.61%30.14K
--30.14K
-General and administrative expense
-35.32%263.21K
-49.61%283.78K
-28.34%326.88K
-31.79%1.36M
-133.65%-69.85K
-59.45%406.95K
48.99%563.21K
13.36%456.18K
586.56%1.99M
86.17%207.56K
Research and development costs
--0
--23.8K
----
----
----
--0
--0
----
----
----
Depreciation amortization depletion
-66.61%6.52K
-66.61%6.52K
-66.60%6.52K
-3.42%74.32K
-66.64%15.77K
90.09%19.52K
89.17%19.52K
114.45%19.52K
228.63%76.95K
1,136.06%47.27K
-Depreciation and amortization
-66.61%6.52K
-66.61%6.52K
-66.60%6.52K
-3.42%74.32K
-66.64%15.77K
90.09%19.52K
89.17%19.52K
114.45%19.52K
228.63%76.95K
1,136.06%47.27K
Other operating expenses
878.43%228.95K
961.10%58.35K
----
-1,363.21%-375.84K
-2,384.88%-421.79K
--23.4K
-51.31%5.5K
--5.5K
323.45%29.75K
1,281.74%18.46K
Operating profit
-22.43%-553.73K
27.29%-453.02K
5.74%-487.59K
46.34%-1.14M
252.94%464.07K
55.39%-452.3K
-55.91%-623.05K
-25.70%-517.29K
-510.00%-2.13M
-142.87%-303.43K
Net non-operating interest income expense
Other net income (expense)
-11.55K
Other non- operating income (expenses)
----
----
----
----
----
----
----
---11.55K
----
----
Income before tax
-22.43%-553.73K
27.29%-453.02K
7.80%-487.59K
46.34%-1.14M
252.94%464.07K
55.39%-452.3K
-55.91%-623.05K
-28.51%-528.84K
-510.00%-2.13M
-142.87%-303.43K
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-22.43%-553.73K
27.29%-453.02K
7.80%-487.59K
46.34%-1.14M
252.94%464.07K
55.39%-452.3K
-55.91%-623.05K
-28.51%-528.84K
-510.00%-2.13M
-142.87%-303.43K
Net income continuous Operations
-22.43%-553.73K
27.29%-453.02K
7.80%-487.59K
46.34%-1.14M
252.94%464.07K
55.39%-452.3K
-55.91%-623.05K
-28.51%-528.84K
-510.00%-2.13M
-142.87%-303.43K
Minority interest income
Net income attributable to the parent company
-22.43%-553.73K
27.29%-453.02K
7.80%-487.59K
46.34%-1.14M
252.94%464.07K
55.39%-452.3K
-55.91%-623.05K
-28.51%-528.84K
-510.00%-2.13M
-142.87%-303.43K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-22.43%-553.73K
27.29%-453.02K
7.80%-487.59K
46.34%-1.14M
252.94%464.07K
55.39%-452.3K
-55.91%-623.05K
-28.51%-528.84K
-510.00%-2.13M
-142.87%-303.43K
Basic earnings per share
0
0
0
50.00%-0.01
0
0
0.00%-0.01
0
-0.02
-125.90%-0.0026
Diluted earnings per share
0
0
0
50.00%-0.01
0
0
0.00%-0.01
0
-0.02
-125.90%-0.0026
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Dec 31, 2025(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q4)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue 0
Gross profit 0
Operating expense 22.43%553.73K-27.29%453.02K-5.74%487.59K-46.34%1.14M-252.94%-464.07K-55.39%452.3K55.91%623.05K25.70%517.29K589.99%2.13M142.86%303.43K
Selling and administrative expenses -22.26%318.26K-39.08%364.35K-2.28%481.07K-28.60%1.44M-124.42%-58.05K-59.21%409.38K58.20%598.03K22.33%492.28K577.58%2.02M98.45%237.71K
-Selling and marketing expense 2,159.85%55.05K131.33%80.56K327.12%154.19K182.53%85.16K-60.84%11.8K--2.44K--34.83K--36.1K263.61%30.14K--30.14K
-General and administrative expense -35.32%263.21K-49.61%283.78K-28.34%326.88K-31.79%1.36M-133.65%-69.85K-59.45%406.95K48.99%563.21K13.36%456.18K586.56%1.99M86.17%207.56K
Research and development costs --0--23.8K--------------0--0------------
Depreciation amortization depletion -66.61%6.52K-66.61%6.52K-66.60%6.52K-3.42%74.32K-66.64%15.77K90.09%19.52K89.17%19.52K114.45%19.52K228.63%76.95K1,136.06%47.27K
-Depreciation and amortization -66.61%6.52K-66.61%6.52K-66.60%6.52K-3.42%74.32K-66.64%15.77K90.09%19.52K89.17%19.52K114.45%19.52K228.63%76.95K1,136.06%47.27K
Other operating expenses 878.43%228.95K961.10%58.35K-----1,363.21%-375.84K-2,384.88%-421.79K--23.4K-51.31%5.5K--5.5K323.45%29.75K1,281.74%18.46K
Operating profit -22.43%-553.73K27.29%-453.02K5.74%-487.59K46.34%-1.14M252.94%464.07K55.39%-452.3K-55.91%-623.05K-25.70%-517.29K-510.00%-2.13M-142.87%-303.43K
Net non-operating interest income expense
Other net income (expense) -11.55K
Other non- operating income (expenses) -------------------------------11.55K--------
Income before tax -22.43%-553.73K27.29%-453.02K7.80%-487.59K46.34%-1.14M252.94%464.07K55.39%-452.3K-55.91%-623.05K-28.51%-528.84K-510.00%-2.13M-142.87%-303.43K
Income tax 0000000000
Net income -22.43%-553.73K27.29%-453.02K7.80%-487.59K46.34%-1.14M252.94%464.07K55.39%-452.3K-55.91%-623.05K-28.51%-528.84K-510.00%-2.13M-142.87%-303.43K
Net income continuous Operations -22.43%-553.73K27.29%-453.02K7.80%-487.59K46.34%-1.14M252.94%464.07K55.39%-452.3K-55.91%-623.05K-28.51%-528.84K-510.00%-2.13M-142.87%-303.43K
Minority interest income
Net income attributable to the parent company -22.43%-553.73K27.29%-453.02K7.80%-487.59K46.34%-1.14M252.94%464.07K55.39%-452.3K-55.91%-623.05K-28.51%-528.84K-510.00%-2.13M-142.87%-303.43K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -22.43%-553.73K27.29%-453.02K7.80%-487.59K46.34%-1.14M252.94%464.07K55.39%-452.3K-55.91%-623.05K-28.51%-528.84K-510.00%-2.13M-142.87%-303.43K
Basic earnings per share 00050.00%-0.01000.00%-0.010-0.02-125.90%-0.0026
Diluted earnings per share 00050.00%-0.01000.00%-0.010-0.02-125.90%-0.0026
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -